Misonix (MSON) Misses Q4 EPS by 2c

Go back to Misonix (MSON) Misses Q4 EPS by 2c

Misonix Reports Fourth Quarter and Fiscal Year 2020 Results

September 3, 2020 4:01 PM EDT

FARMINGDALE, N.Y., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (Misonix or the Company), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today reported unaudited financial results for the fiscal 2020 fourth quarter and full fiscal year ended June 30, 2020 as summarized below:

 Three Months Ended Year Ended June 30, June... More